NEW HAVEN, Conn. (AP) — Melinta Therapeutics Inc. (MLNT) on Tuesday reported a loss of $18.8 million in its fourth quarter.

On a per-share basis, the New Haven, Connecticut-based company said it had a loss of $1.48.

The drugmaker posted revenue of $4.2 million in the period.

For the year, the company reported that its loss narrowed to $58.9 million, or $21.86 per share. Revenue was reported as $33.9 million.

Melinta shares have dropped 15 percent since the beginning of the year. The stock has fallen 25 percent in the last 12 months.

_____

Elements of this story were generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MLNT at https://www.zacks.com/ap/MLNT

_____

This story has been corrected to show that the company has changed its name to Melinta Therapeutics Inc. and relocated to New Haven, Connecticut.